Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BWX Technologies, Inc.BWXT · Entity 656 | Director | September 04, 2026 | September 08, 2026 |
| STANDARD BIOTOOLS INC.LAB · Entity 6116 | Director | June 15, 2022 | June 17, 2022 |
| Sight Sciences, Inc.SGHT · Entity 5537 | Director | June 04, 2026 | June 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BWX Technologies, Inc.
Report date September 04, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 801.11 |
Reported balance
After 2026-09-04 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-04 · Grant · Acquired 23.19 · Balance 801.11 F1: The dividend equivalent rights accrued on seven restricted stock unit grants of which the reporting person has elected to defer receipt of the shares underlying the RSUs. Each RSU and DER represent a contingent right to receive one share of BWXT common stock. In accordance with the deferral election, the DERs will be delivered to the reporting person proportionately with the RSUs to which they relate. |
Filing footnotes · ownership attribution and instrument terms
F1: The dividend equivalent rights accrued on seven restricted stock unit grants of which the reporting person has elected to defer receipt of the shares underlying the RSUs. Each RSU and DER represent a contingent right to receive one share of BWXT common stock. In accordance with the deferral election, the DERs will be delivered to the reporting person proportionately with the RSUs to which they relate.
STANDARD BIOTOOLS INC.
Report date June 15, 2022 · Filed June 17, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 96,827 |
Reported balance
After 2022-06-15 transaction · row 1
1 source rowRow 1 · 2022-06-15 · Grant · Acquired 30,914 · Balance 96,827 F1: Represents Restricted Stock Units that vest in full on the earlier to occur of June 15, 2023 and one day prior to the date of the Issuer's next annual meeting of stockholders. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.86 · Expires 2032-06-15 | Direct | 42,571 |
Reported balance
After 2022-06-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-06-15 · Grant · Acquired 42,571 · Balance 42,571 F2: The Option becomes exercisable in twelve equal monthly increments beginning on July 15, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Restricted Stock Units that vest in full on the earlier to occur of June 15, 2023 and one day prior to the date of the Issuer's next annual meeting of stockholders.
F2: The Option becomes exercisable in twelve equal monthly increments beginning on July 15, 2022.
Sight Sciences, Inc.
Report date June 04, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 123,207 |
Reported balance
After 2026-06-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 28,261 · Balance 123,207 F1: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. F2: Includes (i) 44,922 shares of Common Stock, (ii) 28,261 RSUs which are subject to vesting as reported herein, and (iii) 49,844 RSUs granted to the Reporting Person on 5/12/2025 which are subject to vesting as previously reported. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.
F2: Includes (i) 44,922 shares of Common Stock, (ii) 28,261 RSUs which are subject to vesting as reported herein, and (iii) 49,844 RSUs granted to the Reporting Person on 5/12/2025 which are subject to vesting as previously reported.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 06, 2019 Filed Sep 10, 2019 20:40 UTC | BWX Technologies, Inc. BWXT · Entity 656 | GrantDividend Equivalent Rights · Derivative | 11.1 | $0.00 | $0.00 |
DisclosureSEC source: 0001492627-19-000051 · wf-form4_156814800156880.xml · derivative · entry 1 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38.95 Underlying: Common Stock · 11.1 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued on two restricted stock unit grants of which the reporting person has elected to defer receipt of the shares underlying the RSUs. Each RSU and DER represent a contingent right to receive one share of BWXT common stock. In accordance with the deferral election, the DERs will be delivered to the reporting person proportionately with the RSUs to which they relate. F1 · derivative.exercise_date: The dividend equivalent rights accrued on two restricted stock unit grants of which the reporting person has elected to defer receipt of the shares underlying the RSUs. Each RSU and DER represent a contingent right to receive one share of BWXT common stock. In accordance with the deferral election, the DERs will be delivered to the reporting person proportionately with the RSUs to which they relate. F1 · derivative.expiration_date: The dividend equivalent rights accrued on two restricted stock unit grants of which the reporting person has elected to defer receipt of the shares underlying the RSUs. Each RSU and DER represent a contingent right to receive one share of BWXT common stock. In accordance with the deferral election, the DERs will be delivered to the reporting person proportionately with the RSUs to which they relate. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 20:30 UTC | BWX Technologies, Inc. BWXT · Entity 656 | GrantDividend Equivalent Rights · Derivative | 13.71 | $0.00 | $0.00 |
DisclosureSEC source: 0001492627-19-000035 · wf-form4_155993943026244.xml · derivative · entry 1 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27.85 Underlying: Common Stock · 13.71 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued on two restricted stock unit grants of which the reporting person has elected to defer receipt of the shares underlying the RSUs. Each RSU and DER represent a contingent right to receive one share of BWXT common stock. In accordance with the deferral election, the DERs will be delivered to the reporting person proportionately with the RSUs to which they relate. F1 · derivative.exercise_date: The dividend equivalent rights accrued on two restricted stock unit grants of which the reporting person has elected to defer receipt of the shares underlying the RSUs. Each RSU and DER represent a contingent right to receive one share of BWXT common stock. In accordance with the deferral election, the DERs will be delivered to the reporting person proportionately with the RSUs to which they relate. F1 · derivative.expiration_date: The dividend equivalent rights accrued on two restricted stock unit grants of which the reporting person has elected to defer receipt of the shares underlying the RSUs. Each RSU and DER represent a contingent right to receive one share of BWXT common stock. In accordance with the deferral election, the DERs will be delivered to the reporting person proportionately with the RSUs to which they relate. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 17:41 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantStock Option (Right to Buy) · Derivative | 6,796 | $0.00 Strike: $13.41 | $0.00 |
DisclosureSEC source: 0001162194-19-000053 · wf-form4_155975647068421.xml · derivative · entry 2 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,796 Underlying: Common Stock · 6,796 shares Expires 2029-06-03 F3 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly installments beginning on July 3, 2019. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 17:41 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantCommon Stock | 3,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000053 · wf-form4_155975647068421.xml · nonDerivative · entry 1 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,202 F1 · shares: Represents Restricted Stock Units that vest in full on the earlier to occur of June 3, 2020 and one day prior to the date of the Issuer's next annual meeting of stockholders. The Reporting Person has deferred settlement of the Restricted Stock Units until the earlier to occur of the Reporting Person's termination of service and a change of control. F2 · balance_after: Includes 34,202 vested Restricted Stock Units with respect to which the Reporting Person has deferred settlement as described above. Read SEC document |
| May 14, 2019 Filed May 15, 2019 20:57 UTC | BWX Technologies, Inc. BWXT · Entity 656 | GrantRestricted Stock Units · Derivative | 2,452 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001492627-19-000025 · wf-form4_155795380878935.xml · derivative · entry 1 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,452 Underlying: Common Stock · 2,452 shares Expires not disclosed F1 · kind: Grant of restricted stock units pursuant to the Amended and Restated 2010 Long-Term Incentive Plan of BWX Technologies, Inc. Each restricted stock unit represents a contingent right to receive one share of BWXT common stock. F2 · derivative.exercise_date: RSUs vested immediately. The reporting person elected to defer receipt of shares underlying the RSUs. In accordance with his deferral election, vested shares will be delivered to the reporting person in one lump sum following termination of service on the Board of Directors. F2 · derivative.expiration_date: RSUs vested immediately. The reporting person elected to defer receipt of shares underlying the RSUs. In accordance with his deferral election, vested shares will be delivered to the reporting person in one lump sum following termination of service on the Board of Directors. Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 20:48 UTC | BWX Technologies, Inc. BWXT · Entity 656 | GrantDividend Equivalent Rights · Derivative | 4.96 | $0.00 | $0.00 |
DisclosureSEC source: 0001492627-19-000016 · wf-form4_155415170480467.xml · derivative · entry 1 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14.14 Underlying: Common Stock · 4.96 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued on one restricted stock unit grant of which the reporting person has elected to defer receipt of the shares underlying the RSUs. Each RSU and DER represent a contingent right to receive one share of BWXT common stock. In accordance with the deferral election, the DERs will be delivered to the reporting person proportionately with the RSUs to which they relate. F1 · derivative.exercise_date: The dividend equivalent rights accrued on one restricted stock unit grant of which the reporting person has elected to defer receipt of the shares underlying the RSUs. Each RSU and DER represent a contingent right to receive one share of BWXT common stock. In accordance with the deferral election, the DERs will be delivered to the reporting person proportionately with the RSUs to which they relate. F1 · derivative.expiration_date: The dividend equivalent rights accrued on one restricted stock unit grant of which the reporting person has elected to defer receipt of the shares underlying the RSUs. Each RSU and DER represent a contingent right to receive one share of BWXT common stock. In accordance with the deferral election, the DERs will be delivered to the reporting person proportionately with the RSUs to which they relate. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:38 UTC | BWX Technologies, Inc. BWXT · Entity 656 | GrantDividend Equivalent Rights · Derivative | 5.45 | $0.00 | $0.00 |
DisclosureSEC source: 0001492627-18-000048 · wf-form4_154508267647652.xml · derivative · entry 1 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9.18 Underlying: Common Stock · 5.45 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued on one restricted stock unit grant of which the reporting person has elected to defer receipt of the shares underlying the RSUs. Each RSU and DER represent a contingent right to receive one share of BWXT common stock. In accordance with the deferral election, the DERs will be delivered to the reporting person proportionately with the RSUs to which they relate. F1 · derivative.exercise_date: The dividend equivalent rights accrued on one restricted stock unit grant of which the reporting person has elected to defer receipt of the shares underlying the RSUs. Each RSU and DER represent a contingent right to receive one share of BWXT common stock. In accordance with the deferral election, the DERs will be delivered to the reporting person proportionately with the RSUs to which they relate. F1 · derivative.expiration_date: The dividend equivalent rights accrued on one restricted stock unit grant of which the reporting person has elected to defer receipt of the shares underlying the RSUs. Each RSU and DER represent a contingent right to receive one share of BWXT common stock. In accordance with the deferral election, the DERs will be delivered to the reporting person proportionately with the RSUs to which they relate. Read SEC document |
| September 07, 2018 Filed Sep 11, 2018 21:01 UTC | BWX Technologies, Inc. BWXT · Entity 656 | GrantDividend Equivalent Rights · Derivative | 3.73 | $0.00 | $0.00 |
DisclosureSEC source: 0001492627-18-000036 · wf-form4_153669964674399.xml · derivative · entry 1 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3.73 Underlying: Common Stock · 3.73 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued on one restricted stock unit grant of which the reporting person has elected to defer receipt of the shares underlying the RSUs. Each RSU and DER represent a contingent right to receive one share of BWXT common stock. In accordance with the deferral election, the DERs will be delivered to the reporting person proportionately with the RSUs to which they relate. F1 · derivative.exercise_date: The dividend equivalent rights accrued on one restricted stock unit grant of which the reporting person has elected to defer receipt of the shares underlying the RSUs. Each RSU and DER represent a contingent right to receive one share of BWXT common stock. In accordance with the deferral election, the DERs will be delivered to the reporting person proportionately with the RSUs to which they relate. F1 · derivative.expiration_date: The dividend equivalent rights accrued on one restricted stock unit grant of which the reporting person has elected to defer receipt of the shares underlying the RSUs. Each RSU and DER represent a contingent right to receive one share of BWXT common stock. In accordance with the deferral election, the DERs will be delivered to the reporting person proportionately with the RSUs to which they relate. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 21:00 UTC | BWX Technologies, Inc. BWXT · Entity 656 | GrantRestricted Stock Units · Derivative | 1,434 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001492627-18-000029 · wf-form4_153419400300913.xml · derivative · entry 1 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,434 Underlying: Common Stock · 1,434 shares Expires not disclosed F1 · kind: Grant of restricted stock units pursuant to the Amended and Restated 2010 Long-Term Incentive Plan of BWX Technologies, Inc. Each restricted stock unit represents a contingent right to receive one share of BWXT common stock. F2 · derivative.exercise_date: RSUs vested immediately. The reporting person elected to defer receipt of shares underlying the RSUs. In accordance with his deferral election, vested shares will be delivered to the reporting person in one lump sum following termination of service on the Board of Directors. F2 · derivative.expiration_date: RSUs vested immediately. The reporting person elected to defer receipt of shares underlying the RSUs. In accordance with his deferral election, vested shares will be delivered to the reporting person in one lump sum following termination of service on the Board of Directors. Read SEC document |
| May 31, 2018 Filed Jun 2, 2018 00:55 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantStock Option (Right to Buy) · Derivative | 10,600 | $0.00 Strike: $5.57 | $0.00 |
DisclosureSEC source: 0001162194-18-000075 · wf-form4_152790086939808.xml · derivative · entry 6 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,600 Underlying: Common Stock · 10,600 shares Expires 2028-05-31 F6 · derivative.exercise_date: 1/12th of the shares subject to the Option will vest monthly over twelve months, subject to continued service as a director, such that the Option will be fully vested on May 31, 2019. Read SEC document |
| May 31, 2018 Filed Jun 2, 2018 00:55 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantCommon Stock | 6,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000075 · wf-form4_152790086939808.xml · nonDerivative · entry 3 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,215 F1 · security: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · shares: All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) May 31, 2019, subject to continued service as a director through the vesting date.The Reporting Person has deferred settlement of the Restricted Stock Units to occur within the thirty (30) day period immediately following the earlier to occur of: (a) the Reporting Person's termination of service with the Issuer; or (b) a Change of Control (as defined in the Company's 2011 Equity Incentive Plan). F3 · balance_after: Includes an aggregate of 30,215 vested Restricted Stock Units for which the Reporting Person has deferred settlement as described above. Read SEC document |
| May 30, 2018 Filed Jun 2, 2018 00:55 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000075 · wf-form4_152790086939808.xml · derivative · entry 5 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F5 · derivative.exercise_date: On September 13, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date. F5 · derivative.expiration_date: On September 13, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date. Read SEC document |
| May 30, 2018 Filed Jun 2, 2018 00:55 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000075 · wf-form4_152790086939808.xml · derivative · entry 4 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F4 · derivative.exercise_date: On August 1, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date. F4 · derivative.expiration_date: On August 1, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date. Read SEC document |
| May 30, 2018 Filed Jun 2, 2018 00:55 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000075 · wf-form4_152790086939808.xml · nonDerivative · entry 2 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2018 Filed Jun 2, 2018 00:55 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000075 · wf-form4_152790086939808.xml · nonDerivative · entry 1 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 22:54 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantCommon Stock | 8,597 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000016 · wf-form4_151873524876347.xml · nonDerivative · entry 1 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,115 F1 · shares: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. Subject to the Reporting Person's continued service with the Issuer through each applicable vesting date, twenty-five percent (25%) of the shares underlying the Restricted Stock Units shall vest quarterly on the last day of each quarter during 2018. The Reporting Person has deferred settlement of the Restricted Stock Units to occur within the thirty (30) day period immediately following the earlier to occur of (i) the Reporting Person's termination of service with the Issuer; and (ii) a Change of Control (as defined in the Company's 2011 Equity Incentive Plan). F2 · balance_after: Includes an aggregate of 19,115 vested Restricted Stock Units for which the Reporting Person has deferred settlement as described above. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 21:52 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 5,259 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000008 · wf-form4_151501634474231.xml · derivative · entry 2 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,259 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: Fifty percent (50%) of the shares underlying the Restricted Stock Units vested on September 30, 2017, and the remaining fifty percent (50%) vested on December 31, 2017. F2 · derivative.expiration_date: Fifty percent (50%) of the shares underlying the Restricted Stock Units vested on September 30, 2017, and the remaining fifty percent (50%) vested on December 31, 2017. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 21:52 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 5,259 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000008 · wf-form4_151501634474231.xml · nonDerivative · entry 1 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 00:55 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 5,259 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000154 · wf-form4_150699213541126.xml · derivative · entry 2 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,259 Underlying: Common Stock · 5,259 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: Fifty percent (50%) of the shares underlying the Restricted Stock Units vested on September 30, 2017, and the remaining fifty percent (50%) will vest on December 31, 2017 subject to serving as a director through such date. F2 · derivative.expiration_date: Fifty percent (50%) of the shares underlying the Restricted Stock Units vested on September 30, 2017, and the remaining fifty percent (50%) will vest on December 31, 2017 subject to serving as a director through such date. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 00:55 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 5,259 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000154 · wf-form4_150699213541126.xml · nonDerivative · entry 1 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 01:07 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $5.44 | $0.00 |
DisclosureSEC source: 0001162194-17-000132 · wf-form4_150543761242479.xml · derivative · entry 2 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2027-08-01 F3 · derivative.exercise_date: 1/12th of the total number of shares subject to the Option will vest each month after the Vesting Commencement Date, on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that the Option will be fully vested one year following the Vesting Commencement Date, subject to recipient continuing to serve as a director of the Company through each such vesting date. "Vesting Commencement Date" shall mean August 1, 2017. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 01:07 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000132 · wf-form4_150543761242479.xml · derivative · entry 1 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of (i) one day prior to the date of the next annual meeting of the stockholders of the Company or (ii) August 1, 2018, in each case subject to recipient's continued service as a director through the applicable vest date. F2 · derivative.expiration_date: All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of (i) one day prior to the date of the next annual meeting of the stockholders of the Company or (ii) August 1, 2018, in each case subject to recipient's continued service as a director through the applicable vest date. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 20:45 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 10,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000110 · wf-form4_150239788986579.xml · derivative · entry 1 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,518 Underlying: Common Stock · 10,518 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: Fifty percent (50%) of the shares underlying the Restricted Stock Units will vest on September 30, 2017, and the remaining fifty percent (50%) will vest on December 31, 2017, in each case subject to serving as a director through such date. F2 · derivative.expiration_date: Fifty percent (50%) of the shares underlying the Restricted Stock Units will vest on September 30, 2017, and the remaining fifty percent (50%) will vest on December 31, 2017, in each case subject to serving as a director through such date. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 00:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.43 | $0.00 |
DisclosureSEC source: 0001162194-17-000084 · wf-form4_150172041839168.xml · derivative · entry 4 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2027-08-01 F3 · derivative.exercise_date: 1/12th of the shares subject to the Option will vest monthly, subject to continued service as a director, such that the Option will be fully vested on August 1, 2018. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 00:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000084 · wf-form4_150172041839168.xml · derivative · entry 3 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of one day prior to the date of the next annual meeting of the stockholders of the Company or August 1, 2018, subject to continued service as a director through the vesting date. F2 · derivative.expiration_date: All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of one day prior to the date of the next annual meeting of the stockholders of the Company or August 1, 2018, subject to continued service as a director through the vesting date. Read SEC document |
| July 31, 2017 Filed Aug 3, 2017 00:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000084 · wf-form4_150172041839168.xml · derivative · entry 2 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2017-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. Read SEC document |
| July 31, 2017 Filed Aug 3, 2017 00:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000084 · wf-form4_150172041839168.xml · nonDerivative · entry 1 Burbach Gerhard F · CIK 0001307313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.